1. Home
  2. HRMY vs XRAY Comparison

HRMY vs XRAY Comparison

Compare HRMY & XRAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

N/A

Current Price

$42.11

Market Cap

2.2B

Sector

Health Care

ML Signal

N/A

Logo DENTSPLY SIRONA Inc.

XRAY

DENTSPLY SIRONA Inc.

N/A

Current Price

$11.36

Market Cap

2.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HRMY
XRAY
Founded
2017
1899
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.6B
IPO Year
2020
2009

Fundamental Metrics

Financial Performance
Metric
HRMY
XRAY
Price
$42.11
$11.36
Analyst Decision
Buy
Hold
Analyst Count
9
14
Target Price
$44.11
$14.58
AVG Volume (30 Days)
603.1K
4.0M
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
5.58%
EPS Growth
7.97
33.04
EPS
1.84
0.14
Revenue
$868,453,000.00
N/A
Revenue This Year
$19.75
N/A
Revenue Next Year
$12.88
$2.06
P/E Ratio
$23.20
$81.00
Revenue Growth
21.51
N/A
52 Week Low
$25.52
$9.41
52 Week High
$43.49
$14.73

Technical Indicators

Market Signals
Indicator
HRMY
XRAY
Relative Strength Index (RSI) 69.47 46.50
Support Level $34.87 $10.84
Resistance Level N/A $11.48
Average True Range (ATR) 1.24 0.43
MACD 0.29 0.04
Stochastic Oscillator 86.77 65.33

Price Performance

Historical Comparison
HRMY
XRAY

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

About XRAY DENTSPLY SIRONA Inc.

Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is sold to labs and offices through the firm's salesforce or directly to consumers (such as the Byte clear aligner).

Share on Social Networks: